Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

ViiV Q&A: curing HIV would be “completely revolutionary”

The lives of HIV patients have been dramatically transformed by the development of antiretroviral therapy in the past few decades. However, HIV is still tainted by significant stigma and these therapies are burdensome to patients. ViiV Healthcare head of research and development Dr Kimberly Smith explains the challenges still endured by HIV patients, as well as how the speciality company is seeking to overcome these through long-acting treatments and research into a cure.


Go Top